Clinical inspection readiness perspectives: CRO vs Sponsor

Add bookmark

If your company was handed with a notice for a clinical trial inspection right now, what would the reaction be?  A feeling of calm confidence or a rush of slight concern? In this ebook Pharma IQ compared the perspectives of a Clinical Research Organisation (CRO) to that of a sponsor concerning the burning topic of trial master file inspection readiness.

[inlinead]

Need some tips? Take a look at our interactive inspection ready infographic featuring intel from the MHRA's Senior Good Clinical Practice Inspector Andy Fisher. 

                   

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended